Benefit–risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty

Overview of attention for article published in Vascular Health and Risk Management, March 2014

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (75th percentile)
Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

policy: 1 policy source
twitter: 3 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 28 Dimensions

Readers on

mendeley: 96 Mendeley

Summary Policy documents X Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

Dove Medical Press, 10 Apr 2014

Benefit–risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee…